Scalamogna, Maria
Kuna, Constantin
Voll, Felix
Aytekin, Alp
Lahu, Shqipdona
Kessler, Thorsten
Kufner, Sebastian
Rheude, Tobias
Sager, Hendrik B.
Xhepa, Erion
Wiebe, Jens
Joner, Michael
Ndrepepa, Gjin
Kastrati, Adnan
Cassese, Salvatore
Funding for this research was provided by:
Technische Universität München
Article History
Received: 8 July 2023
Accepted: 12 October 2023
First Online: 6 November 2023
Declarations
:
: Dr Kuna has received speaker fees from AstraZeneca. Dr Kufner has received speaker and consulting fees from AstraZeneca, Bristol-Myers Squibb, and Translumina not related to the current work. Dr Rheude has received speaker fees from AstraZeneca and SIS Medical AG. Dr Joner reports institutional grant support from Boston Scientific, Cardiac Dimensions, Edwards Lifesciences and Infraredx; consulting fees from Biotronik, TriCares, Veryan, and Shockwave; speaker fees from Abbott, AstraZeneca, Biotronik, Boston Scientific, Cardiac Dimensions, Edwards Lifesciences, Recor Medical and Shockwave; participation on a Steering Committee of Biotronik and Edwards Lifesciences; travel support from Boston Scientific, Cardiac Dimensions, Edwards Lifesciences and SIS Medical AG. Dr Xhepa has received lecture fees/honoraria from AstraZeneca, Boston Scientific and SIS Medical AG; and proctoring honoraria from Abbott Vascular; and institutional grant support from Abbott Vascular. Dr Cassese has received lectures/proctoring honoraria from SIS Medical AG; and institutional grant support from Abbott Vascular, Boston Scientific and SIS Medical AG. The other authors declare no potential conflict of interest.
: Not required. The present is a meta-analysis of aggregate data.